CNS pipeline · person

Michael I. Halstead, JD

President of Intra-Cellular Therapies since March 2024. He previously served as General Counsel (2014–2024), Secretary (2014–2024), and Executive Vice President (2019–2024). Before joining the company he held leadership positions at Warner Chilcott plc, most recently as Senior Vice President, Corporate Development, and earlier practiced as an attorney at Davis Polk & Wardwell.

  • 1 company

Current roles

Appears with

People sharing a company with Michael.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.